| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| oncology endpoints fda guidance | 1.82 | 0.3 | 6270 | 46 | 31 |
| oncology | 0.3 | 0.4 | 2619 | 2 | 8 |
| endpoints | 1.19 | 0.7 | 6110 | 91 | 9 |
| fda | 1.53 | 0.5 | 3593 | 74 | 3 |
| guidance | 0.43 | 0.5 | 7587 | 57 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| oncology endpoints fda guidance | 1.88 | 0.9 | 9921 | 67 |
| oncology clinical trial endpoints fda | 0.35 | 0.9 | 637 | 41 |
| fda guidance multiple endpoints | 0.74 | 0.9 | 2708 | 54 |
| fda guidance on clinical trial endpoints | 0.42 | 0.1 | 7974 | 53 |
| fda endpoints in cancer trials | 0.4 | 0.9 | 1040 | 59 |
| clinical endpoints in oncology | 1.87 | 0.8 | 7329 | 14 |
| fda guidance combination oncology | 0.08 | 0.8 | 738 | 96 |
| co-primary endpoints fda guidance | 1.65 | 1 | 1471 | 94 |
| oncology clinical trial endpoints | 1.28 | 0.1 | 3853 | 62 |
| endpoints in oncology clinical trials | 0.26 | 0.5 | 1647 | 85 |
| clinical trial endpoints fda guidelines | 0.38 | 0.8 | 9769 | 58 |
| endpoints in oncology clinical trials ppt | 0.4 | 0.7 | 9581 | 77 |
| fda guidance oncology trial design | 0.51 | 0.5 | 1602 | 99 |
| clinical trial endpoints fda | 1.23 | 0.1 | 7803 | 8 |
| fda office of oncology products | 0.15 | 0.4 | 8078 | 59 |
| fda multiple endpoints in clinical trials | 0.76 | 0.2 | 6553 | 91 |
| fda division of oncology | 0.66 | 1 | 6547 | 18 |
| fda office of oncology drugs | 1.61 | 0.5 | 967 | 17 |
| fda guidance clinical pharmacology | 1.04 | 0.3 | 8313 | 50 |
| fda center for oncology excellence | 0.41 | 0.8 | 8865 | 80 |
